PRE 14A

PROXY STATEMENT

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filed: November 27, 2023
Period of Report: November 27, 2023
Accession Number: 0001213900-23-090212

View Document ↗ View on SEC.gov ↗